Goodwin advised Aerpio Pharmaceuticals, Inc. on its $45.0 million public offering of common stock and uplisting to the Nasdaq Capital Market. The company’s common stock began…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
